This review focusses on immunotherapy-related enterocolitis in patients receiving checkpoint inhibitors. We hope the review can be a useful resource for teaching purposes.
This educational review examines frequency and time-to-onset of adverse reactions, patient education and management, multidisciplinary involvement and provides commentary from Dr Andrew Buckle, a gastroenterologist and molecular biologist with the Peter MacCallum Cancer Centre and Royal Melbourne Hospital.
Please login below to download this issue (PDF)